Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2024 | Apr. 29, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2024 | |
Document Transition Report | false | |
Entity File Number | 001-33155 | |
Entity Registrant Name | IPG PHOTONICS CORP | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 04-3444218 | |
Entity Address, Address Line One | 377 Simarano Drive | |
Entity Address, City or Town | Marlborough | |
Entity Address, State or Province | MA | |
Entity Address, Postal Zip Code | 01752 | |
City Area Code | 508 | |
Local Phone Number | 373-1100 | |
Title of 12(b) Security | Common Stock, par value $0.0001 per share | |
Trading Symbol | IPGP | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding (in shares) | 45,568,197 | |
Amendment Flag | false | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2024 | |
Current Fiscal Year End Date | --12-31 | |
Entity Central Index Key | 0001111928 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 496,452 | $ 514,674 |
Short-term investments | 643,655 | 662,807 |
Accounts receivable, net | 184,012 | 219,053 |
Inventories | 431,899 | 453,874 |
Prepaid income taxes | 24,530 | 26,038 |
Prepaid expenses and other current assets | 49,071 | 38,208 |
Total current assets | 1,829,619 | 1,914,654 |
Deferred income taxes, net | 84,452 | 88,788 |
Goodwill | 38,351 | 38,540 |
Intangible assets, net | 24,802 | 26,234 |
Property, plant and equipment, net | 585,751 | 602,257 |
Other assets | 35,461 | 28,425 |
Total assets | 2,598,436 | 2,698,898 |
Current liabilities: | ||
Accounts payable | 26,675 | 28,618 |
Accrued expenses and other current liabilities | 163,011 | 181,350 |
Income taxes payable | 2,441 | 4,893 |
Total current liabilities | 192,127 | 214,861 |
Other long-term liabilities and deferred income taxes | 65,589 | 68,652 |
Total liabilities | 257,716 | 283,513 |
Commitments and contingencies (Note 10) | ||
IPG Photonics Corporation equity: | ||
Common stock, $0.0001 par value, 175,000,000 shares authorized; 56,521,438 and 45,566,746 shares issued and outstanding, respectively, at March 31, 2024; 56,317,438 and 46,320,671 shares issued and outstanding, respectively, at December 31, 2023. | 6 | 6 |
Treasury stock, at cost, 10,954,692 and 9,996,767 shares held at March 31, 2024 and December 31, 2023, respectively. | (1,251,121) | (1,161,505) |
Additional paid-in capital | 1,002,600 | 994,020 |
Retained earnings | 2,819,493 | 2,795,394 |
Accumulated other comprehensive loss | (230,258) | (212,530) |
Total IPG Photonics Corporation equity | 2,340,720 | 2,415,385 |
Total liabilities and equity | $ 2,598,436 | $ 2,698,898 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2024 | Dec. 31, 2023 |
Statement of Financial Position [Abstract] | ||
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 175,000,000 | 175,000,000 |
Common stock, shares issued | 56,521,438 | 56,317,438 |
Common stock, shares outstanding | 45,566,746 | 46,320,671 |
Treasury stock, common, shares | 10,954,692 | 9,996,767 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Income - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Net sales | $ 252,009 | $ 347,174 |
Cost of sales | 154,473 | 200,236 |
Gross profit | 97,536 | 146,938 |
Operating expenses: | ||
Sales and marketing | 22,998 | 21,088 |
Research and development | 29,381 | 22,770 |
General and administrative | 31,158 | 30,128 |
Gain on sale of assets | (6,776) | 0 |
Restructuring charges, net | 0 | 181 |
Loss (gain) on foreign exchange | 1,675 | (2,655) |
Total operating expenses | 78,436 | 71,512 |
Operating income | 19,100 | 75,426 |
Other income, net: | ||
Interest income, net | 14,177 | 7,533 |
Other income, net | 325 | 331 |
Total other income | 14,502 | 7,864 |
Income before provision for income taxes | 33,602 | 83,290 |
Provision for income taxes | 9,503 | 23,155 |
Net income attributable to IPG Photonics Corporation common stockholders | $ 24,099 | $ 60,135 |
Net income attributable to IPG Photonics Corporation per common share: | ||
Basic (in dollars per share) | $ 0.52 | $ 1.26 |
Diluted (in dollars per share) | $ 0.52 | $ 1.26 |
Weighted average common shares outstanding: | ||
Basic (in shares) | 45,960,476 | 47,542,071 |
Diluted (in shares) | 46,174,518 | 47,776,121 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 24,099 | $ 60,135 |
Other comprehensive (loss) income, net of tax: | ||
Foreign currency translation adjustments and other | (17,728) | 481 |
Unrealized loss on derivatives | 0 | (89) |
Total other comprehensive (loss) income | (17,728) | 392 |
Comprehensive income attributable to IPG Photonics Corporation | $ 6,371 | $ 60,527 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Cash flows from operating activities: | ||
Net income | $ 24,099 | $ 60,135 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
Depreciation and amortization | 16,214 | 17,889 |
Deferred income taxes | 4,044 | 16,106 |
Stock-based compensation | 9,738 | 9,576 |
Unrealized gain on foreign currency transactions | (708) | (1,877) |
Provisions for inventory, warranty and bad debt | 14,761 | 17,214 |
Amortization of premium/discount on investments | (7,218) | (5,316) |
Other | (5,713) | 1,072 |
Changes in assets and liabilities that provided (used) cash, net of acquisitions: | ||
Accounts receivable | 32,305 | (24,642) |
Inventories | 1,498 | (8,989) |
Prepaid expenses and other assets | (7,343) | (10,419) |
Accounts payable | 274 | (4,600) |
Accrued expenses and other liabilities | (26,230) | (19,120) |
Income and other taxes payable | (1,125) | (9,749) |
Net cash provided by operating activities | 54,596 | 37,280 |
Cash flows from investing activities: | ||
Purchases of and deposits on property, plant and equipment | (28,052) | (33,404) |
Proceeds from sales of property, plant and equipment | 25,262 | 1,600 |
Purchases of short-term investments | (226,521) | (343,820) |
Proceeds from short-term investments | 252,890 | 279,499 |
Other | 157 | 107 |
Net cash provided by (used in) investing activities | 23,736 | (96,018) |
Cash flows from financing activities: | ||
Principal payments on long-term borrowings | 0 | (298) |
Proceeds from issuance of common stock under employee stock option and purchase plans less payments for taxes related to net share settlement of equity awards | (1,158) | (3,844) |
Purchase of treasury stock, at cost | (89,616) | (113,094) |
Net cash used in financing activities | (90,774) | (117,236) |
Effect of changes in exchange rates on cash and cash equivalents | (5,780) | (1,098) |
Net decrease in cash and cash equivalents | (18,222) | (177,072) |
Cash and cash equivalents — Beginning of period | 514,674 | 698,209 |
Cash and cash equivalents — End of period | 496,452 | 521,137 |
Supplemental disclosure of cash flow information: | ||
Cash paid for interest | 4 | 525 |
Cash paid for income taxes | 8,005 | 19,203 |
Non-cash transactions: | ||
Demonstration units transferred from inventory to other assets | 1,736 | 1,499 |
Inventory transferred to (from) machinery and equipment | 498 | (554) |
Additions to property, plant and equipment included in accounts payable | 1,708 | 1,109 |
Leased assets obtained in exchange for new operating lease liabilities | $ 2,418 | $ 457 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Equity - USD ($) $ in Thousands | Total | Common Stock | Treasury Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive (Loss) Income |
Balance, beginning of year (in shares) at Dec. 31, 2022 | 48,138,257 | |||||
Balance, beginning of period at Dec. 31, 2022 | $ 2,385,360 | $ 6 | $ (938,009) | $ 951,371 | $ 2,576,516 | $ (204,524) |
Balance, beginning of period (in shares) at Dec. 31, 2022 | (7,879,415) | |||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Exercise of stock options and vesting of RSUs and PSUs, net of shares withheld for taxes (in shares) | 166,063 | |||||
Vesting of RSUs and PSUs, net of shares withheld for taxes, and exercise of stock options | (3,844) | (3,844) | ||||
Purchased common stock (in shares) | (998,769) | (998,769) | ||||
Purchased common stock | (113,094) | $ (113,094) | ||||
Stock-based compensation | 9,576 | 9,576 | ||||
Net income | 60,135 | 60,135 | ||||
Foreign currency translation adjustments and other | 481 | 481 | ||||
Unrealized gain (loss) on derivatives, net of tax | (89) | (89) | ||||
Balance, end of period (in shares) at Mar. 31, 2023 | 47,305,551 | |||||
Balance, end of period at Mar. 31, 2023 | $ 2,338,525 | $ 6 | $ (1,051,103) | 957,103 | 2,636,651 | (204,132) |
Balance, end of period (in shares) at Mar. 31, 2023 | (8,878,184) | |||||
Balance, beginning of year (in shares) at Dec. 31, 2023 | 46,320,671 | 46,320,671 | ||||
Balance, beginning of period at Dec. 31, 2023 | $ 2,415,385 | $ 6 | $ (1,161,505) | 994,020 | 2,795,394 | (212,530) |
Balance, beginning of period (in shares) at Dec. 31, 2023 | (9,996,767) | (9,996,767) | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Exercise of stock options and vesting of RSUs and PSUs, net of shares withheld for taxes (in shares) | 204,000 | |||||
Vesting of RSUs and PSUs, net of shares withheld for taxes, and exercise of stock options | $ (1,158) | (1,158) | ||||
Purchased common stock | (89,616) | $ (89,616) | ||||
Purchased common stock (in shares) | (957,925) | (957,925) | ||||
Stock-based compensation | 9,738 | 9,738 | ||||
Net income | 24,099 | 24,099 | ||||
Foreign currency translation adjustments and other | (17,728) | (17,728) | ||||
Unrealized gain (loss) on derivatives, net of tax | $ 0 | |||||
Balance, end of period (in shares) at Mar. 31, 2024 | 45,566,746 | 45,566,746 | ||||
Balance, end of period at Mar. 31, 2024 | $ 2,340,720 | $ 6 | $ (1,251,121) | $ 1,002,600 | $ 2,819,493 | $ (230,258) |
Balance, end of period (in shares) at Mar. 31, 2024 | (10,954,692) | (10,954,692) |
Basis of Presentation and Signi
Basis of Presentation and Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES | BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation — The accompanying unaudited condensed consolidated financial statements have been prepared by IPG Photonics Corporation, or "IPG", "its" or the "Company". Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). The condensed consolidated financial statements include the Company's accounts and those of its subsidiaries. All intercompany balances have been eliminated in consolidation. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. In the opinion of the Company's management, the financial information for the interim periods presented reflects all adjustments necessary for a fair presentation of the Company's financial position, results of operations and cash flows. The results reported in these condensed consolidated financial statements are not necessarily indicative of results that may be expected for the entire year. Accounts Receivable and Allowance for Credit Losses — The Company maintains an allowance for doubtful accounts to provide for the estimated amount of accounts receivable that will not be collected. The allowance is based upon an estimate of expected credit losses over the life of outstanding receivables. The estimate involves an assessment of customer creditworthiness, historical payment experience, an assumption of future expected credit losses, and the age of outstanding receivables. Activity related to the allowance for doubtful accounts was as follows: Three Months Ended March 31, 2024 2023 Balance, beginning of period $ 1,763 $ 2,639 Provision for bad debts, net of (recoveries) 93 (209) Uncollectible accounts written off (25) (50) Foreign currency translation (14) (17) Balance, end of period $ 1,817 $ 2,363 Comprehensive Income — Comprehensive income includes charges and credits to equity that are not the result of transactions with stockholders. Included within comprehensive income is the cumulative foreign currency translation adjustment and unrealized gains or losses on derivatives. These adjustments are accumulated within the condensed consolidated statements of comprehensive income. Total components of accumulated other comprehensive loss were as follows: Foreign currency translation adjustments and other Unrealized gain (loss) on derivatives, net of tax Total Balance, January 1, 2024 $ (212,530) $ — $ (212,530) Other comprehensive loss, net of tax: Foreign currency translation adjustments and other, net of tax benefit of $33 (17,728) — (17,728) Total other comprehensive loss (17,728) — (17,728) Balance, March 31, 2024 $ (230,258) $ — $ (230,258) Balance, January 1, 2023 $ (204,676) $ 152 $ (204,524) Other comprehensive income (loss), net of tax: Foreign currency translation adjustments and other, net of tax expense of $35 481 — 481 Unrealized loss on derivatives, net of tax benefit of $26 — (89) (89) Total other comprehensive income (loss) 481 (89) 392 Balance, March 31, 2023 $ (204,195) $ 63 $ (204,132) Subsequent Events — The Company has considered the impact of subsequent events through the filing date of these financial statements. There were no events through the filing date of these financial statements required to be disclosed. |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
RECENT ACCOUNTING PRONOUNCEMENTS | RECENT ACCOUNTING PRONOUNCEMENTS Adopted Pronouncements — In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"), which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an annual and interim basis. Under the new guidance an entity is required to disclose the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The ASU also requires that an entity that has a single reportable segment provide all the disclosures required by this ASU and all existing segment disclosures in Topic 280. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted this standard during fiscal year 2024, and will start disclosing the required information in fiscal year ending December 31, 2024. The Company does not expect this standard to have a material impact. Pronouncements Currently Under Evaluation — In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"), which requires an entity on an annual basis to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. The guidance also requires an entity to disclose on an annual basis information about income taxes paid. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The Company is evaluating the impact of this ASU and does not expect this standard will have a material impact. |
Revenue From Contracts With Cus
Revenue From Contracts With Customers | 3 Months Ended |
Mar. 31, 2024 | |
Revenue from Contract with Customer [Abstract] | |
REVENUE FROM CONTRACTS WITH CUSTOMERS | REVENUE FROM CONTRACTS WITH CUSTOMERS Sales are derived from products for different applications: fiber lasers, diode lasers, systems and accessories for materials processing; fiber lasers, diodes and amplifiers for advanced applications; and fiber lasers, systems and fibers for medical applications. The following tables represent a disaggregation of revenue from contracts with customers: Three Months Ended March 31, 2024 2023 Sales by Application Materials processing $ 226,365 $ 312,969 Other applications 25,644 34,205 Total $ 252,009 $ 347,174 Sales by Product High Power Continuous Wave ("CW") Lasers $ 90,793 $ 154,034 Medium Power CW Lasers 16,214 13,839 Pulsed Lasers 34,819 56,147 Quasi-Continuous Wave ("QCW") Lasers 15,791 11,282 Laser and Non-Laser Systems 37,503 41,384 Other Revenue including Amplifiers, Service, Parts, Accessories and Change in Deferred Revenue 56,889 70,488 Total $ 252,009 $ 347,174 Sales by Geography North America $ 63,964 $ 76,080 Europe: Germany 20,019 19,833 Other Europe 59,497 80,420 Asia: China 62,730 101,287 Japan 16,698 21,618 Other Asia 24,978 43,654 Rest of World 4,123 4,282 Total $ 252,009 $ 347,174 Timing of Revenue Recognition Goods and services transferred at a point in time $ 242,527 $ 333,125 Goods and services transferred over time 9,482 14,049 Total $ 252,009 $ 347,174 One of the Company's customers accounted for 21% and 14% of the Company's net accounts receivable as of March 31, 2024 and December 31, 2023, respectively. The Company enters into contracts to sell lasers and spare parts, for which revenue is generally recognized upon shipment or delivery, depending on the terms of the contract. The Company also provides installation services and extended warranties. The Company frequently receives consideration from a customer prior to transferring goods to the customer under the terms of a sales contract. The Company records customer deposits related to these prepayments, which represent a contract liability. The Company also records deferred revenue related to installation services when consideration is received before the services have been performed. The standalone selling price for installation services is determined based on the estimated number of days of service technician time required for installation at standard service rates. The Company recognizes customer deposits and deferred revenue as net sales after control of the goods or services has been transferred to the customer and all revenue recognition criteria are met. The Company bills customers for extended warranties upon entering into the agreement with the customer, resulting in deferred revenue that is recognized over the period of the extended warranty contract. The Company recognizes revenue over time on contracts for the sale of large scale materials processing systems. The timing of customer payments on these contracts generally differs from the timing of revenue recognized. If revenue recognized exceeds customer payments, a contract asset is recorded and if customer payments exceed revenue recognized, a contract liability is recorded. Contract assets are included within prepaid expense and other current assets on the condensed consolidated balance sheets. Contract liabilities are included within accrued expenses and other current liabilities on the condensed consolidated balance sheets. Certain deferred revenues related to extended warranties in excess of one year from the balance sheet date are included within other long-term liabilities and deferred income taxes on the condensed consolidated balance sheets. The following table reflects the changes in the Company's contract assets and liabilities for the three months ended March 31, 2024 and 2023: March 31, January 1, March 31, January 1, 2024 2024 Change 2023 2023 Change Contract assets Contract assets $ 10,996 $ 9,383 $ 1,613 $ 13,806 $ 8,620 $ 5,186 Contract liabilities Contract liabilities - current 60,171 69,219 (9,048) 82,903 80,068 2,835 Contract liabilities - long-term 2,732 2,851 (119) 3,020 3,142 (122) During the three months ended March 31, 2024 and 2023 the Company recognized revenue of $30,500 and $29,012, respectively, that was included in contract liabilities at the beginning of each period. The following table represents the Company's remaining performance obligations from contracts that are recognized over time as of March 31, 2024: Remaining Performance Obligations 2024 (a) 2025 2026 2027 2028 Thereafter Total Revenue expected to be recognized for extended warranty agreements $ 2,398 $ 1,447 $ 927 $ 603 $ 133 $ 53 $ 5,561 Revenue to be earned over time from contracts to sell large scale materials processing systems 14,385 2,200 — — — — 16,585 Total $ 16,783 $ 3,647 $ 927 $ 603 $ 133 $ 53 $ 22,146 (a) For the nine-month period beginning April 1, 2024. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2024 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS The Company's financial instruments consist of cash equivalents, short-term investments, accounts receivable, accounts payable, and revolving lines of credit. The valuation techniques used to measure fair value are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect internal market assumptions. These two types of inputs create the following fair value hierarchy: Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. The Company classifies its financial instruments according to the prescribed criteria. The fair value of money market fund deposits, cash equivalent term deposits, accounts receivable, accounts payable and drawings on revolving lines of credit is reasonably close to their carrying amounts due to the short maturity of most of these instruments or as a result of the competitive market interest rates, which have been negotiated. The fair value of the Company's commercial paper, corporate bonds, U.S. Treasury and agency obligations and term deposits are based on Level 2 inputs. The following table presents fair value information related to the Company's assets and liabilities measured at amortized cost on the condensed consolidated balance sheets: Fair Value Measurements at March 31, 2024 Total Level 1 Level 2 Level 3 Assets Cash equivalents: Money market fund deposits $ 142,100 $ 142,100 $ — $ — Term deposits 74,346 — 74,346 — Corporate bonds 6,736 — 6,736 — Total cash equivalents 223,182 142,100 81,082 — Short-term investments: Commercial paper 282,078 — 282,078 — Corporate bonds 227,995 — 227,995 — U.S. Treasury and agency obligations 130,150 — 130,150 — Term deposits 3,048 — 3,048 — Total short-term investments 643,271 — 643,271 — Total $ 866,453 $ 142,100 $ 724,353 $ — Fair Value Measurements at December 31, 2023 Total Level 1 Level 2 Level 3 Assets Cash equivalents: Money market fund deposits $ 171,632 $ 171,632 $ — $ — Term deposits 83,965 — 83,965 — Corporate bonds 23,516 — 23,516 — Commercial paper 6,369 — 6,369 — Total cash equivalents 285,482 171,632 113,850 — Short-term investments: Commercial paper 244,571 — 244,571 — Corporate bonds 243,915 — 243,915 — U.S. Treasury and agency obligations 171,316 — 171,316 — Term deposits 3,009 — 3,009 — Total short-term investments 662,811 — 662,811 — Total $ 948,293 $ 171,632 $ 776,661 $ — There were no impairments for the investments considered held-to-maturity during the quarters ended March 31, 2024 and 2023. There were no current expected credit loss allowances for the investments considered held-to-maturity at March 31, 2024 and 2023. The Company holds highly-rated held-to-maturity instruments that are within one year of maturity. The following table presents the effective maturity dates of debt investments, which are held-to-maturity: March 31, 2024 December 31, 2023 Book Value Fair Value Book Value Fair Value Investment maturity Less than 1 year $ 643,655 $ 643,271 $ 662,807 $ 662,811 |
Inventories
Inventories | 3 Months Ended |
Mar. 31, 2024 | |
Inventory Disclosure [Abstract] | |
INVENTORIES | INVENTORIES Inventories consist of the following: March 31, December 31, 2024 2023 Components and raw materials $ 249,123 $ 263,652 Work-in-process 43,380 47,997 Finished goods 139,396 142,225 Total $ 431,899 $ 453,874 The Company recorded inventory provisions totaling $12,842 and $12,096 for the three months ended March 31, 2024 and 2023, respectively. These provisions relate to the recoverability of the value of inventories due to technological changes and excess quantities. These provisions are reported as a reduction to components and raw materials, work-in-process and finished goods. |
Goodwill and Intangibles
Goodwill and Intangibles | 3 Months Ended |
Mar. 31, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
GOODWILL AND INTANGIBLES | GOODWILL AND INTANGIBLES The following table sets forth the changes in the carrying amount of goodwill: Three Months Ended March 31, 2024 2023 Balance, beginning of period $ 38,540 $ 38,325 Foreign exchange adjustment (189) 63 Balance, end of period $ 38,351 $ 38,388 Intangible assets, subject to amortization, consisted of the following: March 31, 2024 December 31, 2023 Gross Carrying Amount Accumulated Net Weighted- Average Lives Gross Carrying Amount Accumulated Net Weighted- Customer relationships $ 48,161 $ (26,861) $ 21,300 11 years $ 48,216 $ (25,973) $ 22,243 11 years Technology, trademark and trade name 29,828 (26,326) 3,502 7 years 29,903 (25,960) 3,943 7 years Production know-how 9,122 (9,122) — 7 years 9,155 (9,155) — 7 years Patents 8,034 (8,034) — 8 years 8,035 (7,987) 48 8 years Total $ 95,145 $ (70,343) $ 24,802 $ 95,309 $ (69,075) $ 26,234 Amortization expense for the three months ended March 31, 2024 and 2023 was $1,425 and $2,021, respectively. The estimated future amortization expense for intangibles for the remainder of 2024 and subsequent years is as follows: 2024 (a) 2025 2026 2027 2028 Thereafter Total $ 4,129 $ 4,977 $ 4,217 $ 4,005 $ 3,632 $ 3,842 $ 24,802 (a) For the nine-month period beginning April 1, 2024. |
Other Liabilities
Other Liabilities | 3 Months Ended |
Mar. 31, 2024 | |
Payables and Accruals [Abstract] | |
Other Liabilities | OTHER LIABILITIES Accrued expenses and other current liabilities consist of the following: March 31, December 31, 2024 2023 Contract liabilities $ 60,171 $ 69,219 Accrued compensation 55,322 67,053 Current portion of accrued warranty 25,916 27,283 Short-term lease liabilities 4,574 4,597 Other 17,028 13,198 Total $ 163,011 $ 181,350 Other long-term liabilities and deferred income taxes consist of the following: March 31, December 31, 2024 2023 Accrued warranty $ 17,718 $ 19,926 Transition tax related to 2017 U.S. tax reform act 11,009 11,009 Long-term lease liabilities 14,324 13,664 Unrecognized tax benefits 15,252 17,176 Deferred income taxes 1,507 1,508 Other 5,779 5,369 Total $ 65,589 $ 68,652 |
Product Warranties
Product Warranties | 3 Months Ended |
Mar. 31, 2024 | |
Product Warranties Disclosures [Abstract] | |
PRODUCT WARRANTIES | PRODUCT WARRANTIES The Company typically provides one Activity related to the warranty accrual was as follows: Three Months Ended March 31, 2024 2023 Balance, beginning of period $ 47,209 $ 52,862 Provision for warranty accrual 1,680 4,375 Warranty claims (4,568) (3,798) Foreign currency translation (687) 400 Balance, end of period $ 43,634 $ 53,839 Accrued warranty reported in the accompanying condensed consolidated financial statements as of March 31, 2024 and December 31, 2023 consist of $25,916 and $27,283 in accrued expenses and other current liabilities, respectively, and $17,718 and $19,926 in other long-term liabilities and deferred income taxes, respectively. |
Financing Arrangements
Financing Arrangements | 3 Months Ended |
Mar. 31, 2024 | |
Debt Disclosure [Abstract] | |
FINANCING ARRANGEMENTS | FINANCING ARRANGEMENTS Revolving Line of Credit Facilities: The Company maintains a $75,000 U.S. revolving line of credit, which is available to certain foreign subsidiaries and allows for borrowings in the local currencies of those subsidiaries. At March 31, 2024 and December 31, 2023, there were no amounts drawn on the U.S. line-of-credit, and there were $2,711 and $2,487, respectively, of guarantees issued against the facility, which reduce the amount of the facility available to draw. After providing for the guarantees used, the remaining availability under this line was $72,289 at March 31, 2024. In addition, the Company maintains Euro lines of credit facilities with a total principal amount of €6,500 ($7,014 as of March 31, 2024), which are available to certain European subsidiaries. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | COMMITMENTS AND CONTINGENCIES From time to time, the Company may be involved in legal disputes and other proceedings in the ordinary course of its business. These matters may include allegations of infringement of intellectual property, commercial disputes and employment matters. As of March 31, 2024 and through the filing date of these condensed consolidated financial statements, the Company is aware of no ongoing legal proceedings that management estimates could have a material effect on the Company's Condensed Consolidated Financial Statements. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2024 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES The effective tax rates were 28.3% and 27.8% for the three months ended March 31, 2024 and 2023, respectively. There was a net discrete tax detriment of $1,997 for the three months ended March 31, 2024 and a net discrete tax detriment of $1,972 for the three months ended March 31, 2023. The detriment in 2024 relates primarily to the increase in tax expense for equity-based compensation expense reflected in financial statement income in excess of the deductions allowed for tax purposes. This item was partially offset by a decrease in uncertain tax positions due to the conclusion of tax audits. There was a similar but smaller detriment for equity base compensation in 2023. The Company accounts for its uncertain tax positions in accordance with the accounting standards for income taxes. The Company classifies interest and penalties related to unrecognized tax benefits as a component of the provision for income taxes. The following is a summary of the activity of the Company’s unrecognized tax benefits for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 2023 Balance, beginning of period $ 17,176 $ 15,841 Change in prior period positions (2,000) 42 Additions for tax positions in current period 76 — Foreign currency translation — (78) Balance, end of period $ 15,252 $ 15,805 |
Net Income Attributable to IPG
Net Income Attributable to IPG Photonics Corporation Per Common Share | 3 Months Ended |
Mar. 31, 2024 | |
Earnings Per Share [Abstract] | |
NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION PER COMMON SHARE | NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION PER COMMON SHARE The following table sets forth the computation of diluted net income attributable to IPG Photonics Corporation per common share following the treasury stock method: Three Months Ended March 31, 2024 2023 Net income attributable to IPG Photonics Corporation common stockholders $ 24,099 $ 60,135 Basic weighted average common shares 45,960,476 47,542,071 Dilutive effect of common stock equivalents 214,042 234,050 Diluted weighted average common shares 46,174,518 47,776,121 Basic net income attributable to IPG Photonics Corporation per common share $ 0.52 $ 1.26 Diluted net income attributable to IPG Photonics Corporation per common share $ 0.52 $ 1.26 The computation of diluted weighted average common shares excludes common stock equivalents including non-qualified stock options, performance stock units ("PSUs"), restricted stock units ("RSUs") and employee stock purchase plan ("ESPP") because the effect of including them would be anti-dilutive. The weighted average anti-dilutive shares outstanding for the three months ended March 31, 2024 and 2023 were as follows: Three Months Ended March 31, 2024 2023 Non-qualified stock options 592,393 543,408 Restricted stock units 239,769 346,729 Performance stock units — 30,860 Employee stock purchase plan 9,126 — Total weighed average anti-dilutive shares outstanding 841,288 920,997 On February 13, 2024, the Company announced that its Board of Directors has authorized the purchase of up to $300,000 of IPG common stock. This authorization is in addition to the Company's stock repurchase programs authorized in May 2023. For the three months ended March 31, 2024, the Company repurchased 957,925 under the May 2023 authorization with a weighted average price of $92.73 per share in the open market. The impact on the reduction of weighted average shares for the three months ended March 31, 2024 was 436,884 shares. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Pay vs Performance Disclosure | ||
Net Income (Loss) Attributable to Parent | $ 24,099 | $ 60,135 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Mar. 31, 2024 shares | |
Trading Arrangements, by Individual | |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Angelo P. Lopresti [Member] | |
Trading Arrangements, by Individual | |
Material Terms of Trading Arrangement | on March 12, 2024, Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary, adopted a Rule 10b5-1 trading arrangement for the sale of up to 10,000 shares, over a period beginning June 13, 2024 and ending June 12, 2025 on the open market at prevailing prices, subject to minimum price thresholds. |
Name | Angelo P. Lopresti |
Title | Senior Vice President, General Counsel and Corporate Secretary |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | March 12, 2024 |
Arrangement Duration | 364 days |
Aggregate Available | 10,000 |
Basis of Presentation and Sig_2
Basis of Presentation and Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation — The accompanying unaudited condensed consolidated financial statements have been prepared by IPG Photonics Corporation, or "IPG", "its" or the "Company". Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). The condensed consolidated financial statements include the Company's accounts and those of its subsidiaries. All intercompany balances have been eliminated in consolidation. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. |
Accounts Receivable and Allowance for Doubtful Accounts | Accounts Receivable and Allowance for Credit Losses — The Company maintains an allowance for doubtful accounts to provide for the estimated amount of accounts receivable that will not be collected. The allowance is based upon an estimate of expected credit losses over the life of outstanding receivables. The estimate involves an assessment of customer creditworthiness, historical payment experience, an assumption of future expected credit losses, and the age of outstanding receivables. |
Adopted Pronouncements And Other Pronouncements Currently Under Evaluation | Adopted Pronouncements — In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"), which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an annual and interim basis. Under the new guidance an entity is required to disclose the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The ASU also requires that an entity that has a single reportable segment provide all the disclosures required by this ASU and all existing segment disclosures in Topic 280. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted this standard during fiscal year 2024, and will start disclosing the required information in fiscal year ending December 31, 2024. The Company does not expect this standard to have a material impact. Pronouncements Currently Under Evaluation — In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"), which requires an entity on an annual basis to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. The guidance also requires an entity to disclose on an annual basis information about income taxes paid. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The Company is evaluating the impact of this ASU and does not expect this standard will have a material impact. |
Basis of Presentation and Sig_3
Basis of Presentation and Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Allowance for Doubtful Accounts | Activity related to the allowance for doubtful accounts was as follows: Three Months Ended March 31, 2024 2023 Balance, beginning of period $ 1,763 $ 2,639 Provision for bad debts, net of (recoveries) 93 (209) Uncollectible accounts written off (25) (50) Foreign currency translation (14) (17) Balance, end of period $ 1,817 $ 2,363 |
Schedule of Accumulated Other Comprehensive Income (Loss) | Total components of accumulated other comprehensive loss were as follows: Foreign currency translation adjustments and other Unrealized gain (loss) on derivatives, net of tax Total Balance, January 1, 2024 $ (212,530) $ — $ (212,530) Other comprehensive loss, net of tax: Foreign currency translation adjustments and other, net of tax benefit of $33 (17,728) — (17,728) Total other comprehensive loss (17,728) — (17,728) Balance, March 31, 2024 $ (230,258) $ — $ (230,258) Balance, January 1, 2023 $ (204,676) $ 152 $ (204,524) Other comprehensive income (loss), net of tax: Foreign currency translation adjustments and other, net of tax expense of $35 481 — 481 Unrealized loss on derivatives, net of tax benefit of $26 — (89) (89) Total other comprehensive income (loss) 481 (89) 392 Balance, March 31, 2023 $ (204,195) $ 63 $ (204,132) |
Revenue From Contracts With C_2
Revenue From Contracts With Customers (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following tables represent a disaggregation of revenue from contracts with customers: Three Months Ended March 31, 2024 2023 Sales by Application Materials processing $ 226,365 $ 312,969 Other applications 25,644 34,205 Total $ 252,009 $ 347,174 Sales by Product High Power Continuous Wave ("CW") Lasers $ 90,793 $ 154,034 Medium Power CW Lasers 16,214 13,839 Pulsed Lasers 34,819 56,147 Quasi-Continuous Wave ("QCW") Lasers 15,791 11,282 Laser and Non-Laser Systems 37,503 41,384 Other Revenue including Amplifiers, Service, Parts, Accessories and Change in Deferred Revenue 56,889 70,488 Total $ 252,009 $ 347,174 Sales by Geography North America $ 63,964 $ 76,080 Europe: Germany 20,019 19,833 Other Europe 59,497 80,420 Asia: China 62,730 101,287 Japan 16,698 21,618 Other Asia 24,978 43,654 Rest of World 4,123 4,282 Total $ 252,009 $ 347,174 Timing of Revenue Recognition Goods and services transferred at a point in time $ 242,527 $ 333,125 Goods and services transferred over time 9,482 14,049 Total $ 252,009 $ 347,174 |
Changes in Contract Assets and Liabilities | The following table reflects the changes in the Company's contract assets and liabilities for the three months ended March 31, 2024 and 2023: March 31, January 1, March 31, January 1, 2024 2024 Change 2023 2023 Change Contract assets Contract assets $ 10,996 $ 9,383 $ 1,613 $ 13,806 $ 8,620 $ 5,186 Contract liabilities Contract liabilities - current 60,171 69,219 (9,048) 82,903 80,068 2,835 Contract liabilities - long-term 2,732 2,851 (119) 3,020 3,142 (122) |
Schedule of Remaining Performance Obligations | The following table represents the Company's remaining performance obligations from contracts that are recognized over time as of March 31, 2024: Remaining Performance Obligations 2024 (a) 2025 2026 2027 2028 Thereafter Total Revenue expected to be recognized for extended warranty agreements $ 2,398 $ 1,447 $ 927 $ 603 $ 133 $ 53 $ 5,561 Revenue to be earned over time from contracts to sell large scale materials processing systems 14,385 2,200 — — — — 16,585 Total $ 16,783 $ 3,647 $ 927 $ 603 $ 133 $ 53 $ 22,146 (a) For the nine-month period beginning April 1, 2024. |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Fair Value Disclosures [Abstract] | |
Assets and Liabilities Measured at Fair Value | The following table presents fair value information related to the Company's assets and liabilities measured at amortized cost on the condensed consolidated balance sheets: Fair Value Measurements at March 31, 2024 Total Level 1 Level 2 Level 3 Assets Cash equivalents: Money market fund deposits $ 142,100 $ 142,100 $ — $ — Term deposits 74,346 — 74,346 — Corporate bonds 6,736 — 6,736 — Total cash equivalents 223,182 142,100 81,082 — Short-term investments: Commercial paper 282,078 — 282,078 — Corporate bonds 227,995 — 227,995 — U.S. Treasury and agency obligations 130,150 — 130,150 — Term deposits 3,048 — 3,048 — Total short-term investments 643,271 — 643,271 — Total $ 866,453 $ 142,100 $ 724,353 $ — Fair Value Measurements at December 31, 2023 Total Level 1 Level 2 Level 3 Assets Cash equivalents: Money market fund deposits $ 171,632 $ 171,632 $ — $ — Term deposits 83,965 — 83,965 — Corporate bonds 23,516 — 23,516 — Commercial paper 6,369 — 6,369 — Total cash equivalents 285,482 171,632 113,850 — Short-term investments: Commercial paper 244,571 — 244,571 — Corporate bonds 243,915 — 243,915 — U.S. Treasury and agency obligations 171,316 — 171,316 — Term deposits 3,009 — 3,009 — Total short-term investments 662,811 — 662,811 — Total $ 948,293 $ 171,632 $ 776,661 $ — |
Schedule of Effective Maturity Dates of Held to Maturity Investments | The following table presents the effective maturity dates of debt investments, which are held-to-maturity: March 31, 2024 December 31, 2023 Book Value Fair Value Book Value Fair Value Investment maturity Less than 1 year $ 643,655 $ 643,271 $ 662,807 $ 662,811 |
Inventories (Tables)
Inventories (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Inventory Disclosure [Abstract] | |
Components of Inventories | Inventories consist of the following: March 31, December 31, 2024 2023 Components and raw materials $ 249,123 $ 263,652 Work-in-process 43,380 47,997 Finished goods 139,396 142,225 Total $ 431,899 $ 453,874 |
Goodwill and Intangibles (Table
Goodwill and Intangibles (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Goodwill | The following table sets forth the changes in the carrying amount of goodwill: Three Months Ended March 31, 2024 2023 Balance, beginning of period $ 38,540 $ 38,325 Foreign exchange adjustment (189) 63 Balance, end of period $ 38,351 $ 38,388 |
Schedule of Intangible Assets | Intangible assets, subject to amortization, consisted of the following: March 31, 2024 December 31, 2023 Gross Carrying Amount Accumulated Net Weighted- Average Lives Gross Carrying Amount Accumulated Net Weighted- Customer relationships $ 48,161 $ (26,861) $ 21,300 11 years $ 48,216 $ (25,973) $ 22,243 11 years Technology, trademark and trade name 29,828 (26,326) 3,502 7 years 29,903 (25,960) 3,943 7 years Production know-how 9,122 (9,122) — 7 years 9,155 (9,155) — 7 years Patents 8,034 (8,034) — 8 years 8,035 (7,987) 48 8 years Total $ 95,145 $ (70,343) $ 24,802 $ 95,309 $ (69,075) $ 26,234 |
Estimated Future Amortization Expense for Intangibles | The estimated future amortization expense for intangibles for the remainder of 2024 and subsequent years is as follows: 2024 (a) 2025 2026 2027 2028 Thereafter Total $ 4,129 $ 4,977 $ 4,217 $ 4,005 $ 3,632 $ 3,842 $ 24,802 (a) For the nine-month period beginning April 1, 2024. |
Other Liabilities (Tables)
Other Liabilities (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Payables and Accruals [Abstract] | |
Components of Accrued Expenses and Other Liabilities | Accrued expenses and other current liabilities consist of the following: March 31, December 31, 2024 2023 Contract liabilities $ 60,171 $ 69,219 Accrued compensation 55,322 67,053 Current portion of accrued warranty 25,916 27,283 Short-term lease liabilities 4,574 4,597 Other 17,028 13,198 Total $ 163,011 $ 181,350 |
Other Noncurrent Liabilities | Other long-term liabilities and deferred income taxes consist of the following: March 31, December 31, 2024 2023 Accrued warranty $ 17,718 $ 19,926 Transition tax related to 2017 U.S. tax reform act 11,009 11,009 Long-term lease liabilities 14,324 13,664 Unrecognized tax benefits 15,252 17,176 Deferred income taxes 1,507 1,508 Other 5,779 5,369 Total $ 65,589 $ 68,652 |
Product Warranties (Tables)
Product Warranties (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Product Warranties Disclosures [Abstract] | |
Summary of Product Warranty Activity | Activity related to the warranty accrual was as follows: Three Months Ended March 31, 2024 2023 Balance, beginning of period $ 47,209 $ 52,862 Provision for warranty accrual 1,680 4,375 Warranty claims (4,568) (3,798) Foreign currency translation (687) 400 Balance, end of period $ 43,634 $ 53,839 |
Income Taxes (Tables)
Income Taxes (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Income Tax Disclosure [Abstract] | |
Schedule of Unrecognized Tax Benefits | The following is a summary of the activity of the Company’s unrecognized tax benefits for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 2023 Balance, beginning of period $ 17,176 $ 15,841 Change in prior period positions (2,000) 42 Additions for tax positions in current period 76 — Foreign currency translation — (78) Balance, end of period $ 15,252 $ 15,805 |
Net Income Attributable to IP_2
Net Income Attributable to IPG Photonics Corporation Per Common Share (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Earnings Per Share [Abstract] | |
Computation of Diluted Net Income Per Share | The following table sets forth the computation of diluted net income attributable to IPG Photonics Corporation per common share following the treasury stock method: Three Months Ended March 31, 2024 2023 Net income attributable to IPG Photonics Corporation common stockholders $ 24,099 $ 60,135 Basic weighted average common shares 45,960,476 47,542,071 Dilutive effect of common stock equivalents 214,042 234,050 Diluted weighted average common shares 46,174,518 47,776,121 Basic net income attributable to IPG Photonics Corporation per common share $ 0.52 $ 1.26 Diluted net income attributable to IPG Photonics Corporation per common share $ 0.52 $ 1.26 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The weighted average anti-dilutive shares outstanding for the three months ended March 31, 2024 and 2023 were as follows: Three Months Ended March 31, 2024 2023 Non-qualified stock options 592,393 543,408 Restricted stock units 239,769 346,729 Performance stock units — 30,860 Employee stock purchase plan 9,126 — Total weighed average anti-dilutive shares outstanding 841,288 920,997 |
Basis of Presentation and Sig_4
Basis of Presentation and Significant Accounting Policies (Allowance for Doubtful Accounts) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | ||
Balance, beginning of period | $ 1,763 | $ 2,639 |
Provision for bad debts, net of (recoveries) | 93 | (209) |
Uncollectible accounts written off | (25) | (50) |
Foreign currency translation | (14) | (17) |
Balance, end of period | $ 1,817 | $ 2,363 |
Basis of Presentation and Sig_5
Basis of Presentation and Significant Accounting Policies (Components of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
AOCI [Roll Forward] | ||
Balance, beginning of period | $ 2,415,385 | $ 2,385,360 |
Foreign currency translation adjustments and other, net of tax expense | (17,728) | 481 |
Unrealized gain (loss) on derivatives, net of tax expense | (89) | |
Total other comprehensive income (loss) | (17,728) | 392 |
Balance, end of period | 2,340,720 | 2,338,525 |
Accumulated Other Comprehensive (Loss) Income | ||
AOCI [Roll Forward] | ||
Balance, beginning of period | (212,530) | (204,524) |
Balance, end of period | (230,258) | (204,132) |
Foreign currency translation adjustments and other | ||
AOCI [Roll Forward] | ||
Balance, beginning of period | (212,530) | (204,676) |
Foreign currency translation adjustments and other, net of tax expense | (17,728) | 481 |
Total other comprehensive income (loss) | (17,728) | 481 |
Balance, end of period | (230,258) | (204,195) |
Other comprehensive income (loss), tax, portion attributable to parent | 33 | (35) |
Unrealized gain (loss) on derivatives, net of tax | ||
AOCI [Roll Forward] | ||
Balance, beginning of period | 0 | 152 |
Unrealized gain (loss) on derivatives, net of tax expense | (89) | |
Total other comprehensive income (loss) | 0 | (89) |
Balance, end of period | $ 0 | 63 |
Other comprehensive income (loss), tax, portion attributable to parent | $ 26 |
Revenue From Contracts With C_3
Revenue From Contracts With Customers (Disaggregation of Revenue, By Application) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Sales by Application | ||
Total | $ 252,009 | $ 347,174 |
Materials processing | ||
Sales by Application | ||
Total | 226,365 | 312,969 |
Other applications | ||
Sales by Application | ||
Total | $ 25,644 | $ 34,205 |
Revenue From Contracts With C_4
Revenue From Contracts With Customers (Disaggregation of Revenue, By Product) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Disaggregation of Revenue [Line Items] | ||
Total | $ 252,009 | $ 347,174 |
High Power Continuous Wave ("CW") Lasers | ||
Disaggregation of Revenue [Line Items] | ||
Total | 90,793 | 154,034 |
Medium Power CW Lasers | ||
Disaggregation of Revenue [Line Items] | ||
Total | 16,214 | 13,839 |
Pulsed Lasers | ||
Disaggregation of Revenue [Line Items] | ||
Total | 34,819 | 56,147 |
Quasi-Continuous Wave ("QCW") Lasers | ||
Disaggregation of Revenue [Line Items] | ||
Total | 15,791 | 11,282 |
Laser and Non-Laser Systems | ||
Disaggregation of Revenue [Line Items] | ||
Total | 37,503 | 41,384 |
Other Revenue including Amplifiers, Service, Parts, Accessories and Change in Deferred Revenue | ||
Disaggregation of Revenue [Line Items] | ||
Total | $ 56,889 | $ 70,488 |
Revenue From Contracts With C_5
Revenue From Contracts With Customers (Disaggregation of Revenue, By Geography) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Sales by Geography | ||
Total | $ 252,009 | $ 347,174 |
North America | ||
Sales by Geography | ||
Total | 63,964 | 76,080 |
Germany | ||
Sales by Geography | ||
Total | 20,019 | 19,833 |
Other Europe | ||
Sales by Geography | ||
Total | 59,497 | 80,420 |
China | ||
Sales by Geography | ||
Total | 62,730 | 101,287 |
Japan | ||
Sales by Geography | ||
Total | 16,698 | 21,618 |
Other Asia | ||
Sales by Geography | ||
Total | 24,978 | 43,654 |
Rest of World | ||
Sales by Geography | ||
Total | $ 4,123 | $ 4,282 |
Revenue From Contracts With C_6
Revenue From Contracts With Customers (Disaggregation of Revenue, By Timing) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Timing of Revenue Recognition | ||
Total | $ 252,009 | $ 347,174 |
Goods and services transferred at a point in time | ||
Timing of Revenue Recognition | ||
Total | 242,527 | 333,125 |
Goods and services transferred over time | ||
Timing of Revenue Recognition | ||
Total | $ 9,482 | $ 14,049 |
Revenue From Contracts With C_7
Revenue From Contracts With Customers (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Concentration Risk [Line Items] | |||
Revenue recognized that was included in the contract liability balance at the beginning of the period | $ 30,500 | $ 29,012 | |
One Customer | Customer Concentration Risk | Accounts Receivable | |||
Concentration Risk [Line Items] | |||
Concentration risk, percentage | 21% | 14% |
Revenue From Contracts With C_8
Revenue From Contracts With Customers (Changes in Contract Assets and Contract Liabilities) (Details) - USD ($) $ in Thousands | 3 Months Ended | |||
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Contract assets | ||||
Contract assets | $ 10,996 | $ 13,806 | $ 9,383 | $ 8,620 |
Contract assets, change | 1,613 | 5,186 | ||
Contract liabilities | ||||
Contract liabilities - current | 60,171 | 82,903 | 69,219 | 80,068 |
Contract liabilities - current, change | (9,048) | 2,835 | ||
Contract liabilities - long-term | 2,732 | 3,020 | $ 2,851 | $ 3,142 |
Contract liabilities - long-term, change | $ (119) | $ (122) |
Revenue From Contracts With C_9
Revenue From Contracts With Customers (Schedule of Remaining Performance Obligations) (Details) $ in Thousands | Mar. 31, 2024 USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 22,146 |
Revenue expected to be recognized for extended warranty agreements | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | 5,561 |
Revenue to be earned over time from contracts to sell large scale materials processing systems | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | 16,585 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 16,783 |
Remaining performance obligations, expected timing | 9 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 | Revenue expected to be recognized for extended warranty agreements | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 2,398 |
Remaining performance obligations, expected timing | 9 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 | Revenue to be earned over time from contracts to sell large scale materials processing systems | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 14,385 |
Remaining performance obligations, expected timing | 9 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 3,647 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | Revenue expected to be recognized for extended warranty agreements | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 1,447 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | Revenue to be earned over time from contracts to sell large scale materials processing systems | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 2,200 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 927 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | Revenue expected to be recognized for extended warranty agreements | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 927 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01 | Revenue to be earned over time from contracts to sell large scale materials processing systems | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 0 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 603 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01 | Revenue expected to be recognized for extended warranty agreements | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 603 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01 | Revenue to be earned over time from contracts to sell large scale materials processing systems | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 0 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 133 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01 | Revenue expected to be recognized for extended warranty agreements | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 133 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01 | Revenue to be earned over time from contracts to sell large scale materials processing systems | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 0 |
Remaining performance obligations, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 53 |
Remaining performance obligations, expected timing | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-01-01 | Revenue expected to be recognized for extended warranty agreements | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 53 |
Remaining performance obligations, expected timing | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-01-01 | Revenue to be earned over time from contracts to sell large scale materials processing systems | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 0 |
Remaining performance obligations, expected timing |
Fair Value Measurements (Assets
Fair Value Measurements (Assets and Liabilities Measured at Fair Value) (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Assets | ||
Cash equivalents | $ 223,182 | $ 285,482 |
Short-term investments | 643,271 | 662,811 |
Total | 866,453 | 948,293 |
Commercial paper | ||
Assets | ||
Short-term investments | 282,078 | 244,571 |
Corporate bonds | ||
Assets | ||
Short-term investments | 227,995 | 243,915 |
U.S. Treasury and agency obligations | ||
Assets | ||
Short-term investments | 130,150 | 171,316 |
Term deposits | ||
Assets | ||
Short-term investments | 3,048 | 3,009 |
Money market fund deposits | ||
Assets | ||
Cash equivalents | 142,100 | 171,632 |
Term deposits | ||
Assets | ||
Cash equivalents | 74,346 | 83,965 |
Corporate bonds | ||
Assets | ||
Cash equivalents | 6,736 | 23,516 |
Commercial paper | ||
Assets | ||
Cash equivalents | 6,369 | |
Level 1 | ||
Assets | ||
Cash equivalents | 142,100 | 171,632 |
Short-term investments | 0 | 0 |
Total | 142,100 | 171,632 |
Level 1 | Commercial paper | ||
Assets | ||
Short-term investments | 0 | 0 |
Level 1 | Corporate bonds | ||
Assets | ||
Short-term investments | 0 | 0 |
Level 1 | U.S. Treasury and agency obligations | ||
Assets | ||
Short-term investments | 0 | 0 |
Level 1 | Term deposits | ||
Assets | ||
Short-term investments | 0 | 0 |
Level 1 | Money market fund deposits | ||
Assets | ||
Cash equivalents | 142,100 | 171,632 |
Level 1 | Term deposits | ||
Assets | ||
Cash equivalents | 0 | 0 |
Level 1 | Corporate bonds | ||
Assets | ||
Cash equivalents | 0 | 0 |
Level 1 | Commercial paper | ||
Assets | ||
Cash equivalents | 0 | |
Level 2 | ||
Assets | ||
Cash equivalents | 81,082 | 113,850 |
Short-term investments | 643,271 | 662,811 |
Total | 724,353 | 776,661 |
Level 2 | Commercial paper | ||
Assets | ||
Short-term investments | 282,078 | 244,571 |
Level 2 | Corporate bonds | ||
Assets | ||
Short-term investments | 227,995 | 243,915 |
Level 2 | U.S. Treasury and agency obligations | ||
Assets | ||
Short-term investments | 130,150 | 171,316 |
Level 2 | Term deposits | ||
Assets | ||
Short-term investments | 3,048 | 3,009 |
Level 2 | Money market fund deposits | ||
Assets | ||
Cash equivalents | 0 | 0 |
Level 2 | Term deposits | ||
Assets | ||
Cash equivalents | 74,346 | 83,965 |
Level 2 | Corporate bonds | ||
Assets | ||
Cash equivalents | 6,736 | 23,516 |
Level 2 | Commercial paper | ||
Assets | ||
Cash equivalents | 6,369 | |
Level 3 | ||
Assets | ||
Cash equivalents | 0 | 0 |
Short-term investments | 0 | 0 |
Total | 0 | 0 |
Level 3 | Commercial paper | ||
Assets | ||
Short-term investments | 0 | 0 |
Level 3 | Corporate bonds | ||
Assets | ||
Short-term investments | 0 | 0 |
Level 3 | U.S. Treasury and agency obligations | ||
Assets | ||
Short-term investments | 0 | 0 |
Level 3 | Term deposits | ||
Assets | ||
Short-term investments | 0 | 0 |
Level 3 | Money market fund deposits | ||
Assets | ||
Cash equivalents | 0 | 0 |
Level 3 | Term deposits | ||
Assets | ||
Cash equivalents | 0 | 0 |
Level 3 | Corporate bonds | ||
Assets | ||
Cash equivalents | $ 0 | 0 |
Level 3 | Commercial paper | ||
Assets | ||
Cash equivalents | $ 0 |
Fair Value Measurements (Narrat
Fair Value Measurements (Narrative) (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | ||
Held-to-maturity impairment | $ 0 | $ 0 |
Allowance for credit loss | $ 0 | $ 0 |
Fair Value Measurements (Schedu
Fair Value Measurements (Schedule of Effective Maturity Dates of Held to Maturity Investments) (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Investment maturity | ||
Held-to-maturity maturities, less than 1 year, book value | $ 643,655 | $ 662,807 |
Held-to-maturity maturities, less than 1 year, fair value | $ 643,271 | $ 662,811 |
Inventories (Components Of Inve
Inventories (Components Of Inventories) (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Inventory Disclosure [Abstract] | ||
Components and raw materials | $ 249,123 | $ 263,652 |
Work-in-process | 43,380 | 47,997 |
Finished goods | 139,396 | 142,225 |
Total | $ 431,899 | $ 453,874 |
Inventories (Narrative) (Detail
Inventories (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Inventory Disclosure [Abstract] | ||
Inventory provisions | $ 12,842 | $ 12,096 |
Goodwill and Intangibles (Sched
Goodwill and Intangibles (Schedule of Changes) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Goodwill [Roll Forward] | ||
Balance, beginning of period | $ 38,540 | $ 38,325 |
Foreign exchange adjustment | (189) | 63 |
Balance, end of period | $ 38,351 | $ 38,388 |
Goodwill and Intangibles (Intan
Goodwill and Intangibles (Intangible Assets) (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 95,145 | $ 95,309 |
Accumulated Amortization | (70,343) | (69,075) |
Net Carrying Amount | 24,802 | 26,234 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 48,161 | 48,216 |
Accumulated Amortization | (26,861) | (25,973) |
Net Carrying Amount | $ 21,300 | $ 22,243 |
Weighted- Average Lives | 11 years | 11 years |
Technology, trademark and trade name | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 29,828 | $ 29,903 |
Accumulated Amortization | (26,326) | (25,960) |
Net Carrying Amount | $ 3,502 | $ 3,943 |
Weighted- Average Lives | 7 years | 7 years |
Production know-how | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 9,122 | $ 9,155 |
Accumulated Amortization | (9,122) | (9,155) |
Net Carrying Amount | $ 0 | $ 0 |
Weighted- Average Lives | 7 years | 7 years |
Patents | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 8,034 | $ 8,035 |
Accumulated Amortization | (8,034) | (7,987) |
Net Carrying Amount | $ 0 | $ 48 |
Weighted- Average Lives | 8 years | 8 years |
Goodwill and Intangibles (Narra
Goodwill and Intangibles (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Amortization expense | $ 1,425 | $ 2,021 |
Goodwill and Intangibles (Estim
Goodwill and Intangibles (Estimated Future Amortization Expense for Intangibles) (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
2024 | $ 4,129 | |
2025 | 4,977 | |
2026 | 4,217 | |
2027 | 4,005 | |
2028 | 3,632 | |
Thereafter | 3,842 | |
Net Carrying Amount | $ 24,802 | $ 26,234 |
Other Liabilities (Components o
Other Liabilities (Components of Accrued Expenses and Other Liabilities) (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 | Dec. 31, 2022 |
Payables and Accruals [Abstract] | ||||
Contract liabilities | $ 60,171 | $ 69,219 | $ 82,903 | $ 80,068 |
Accrued compensation | 55,322 | 67,053 | ||
Current portion of accrued warranty | 25,916 | 27,283 | ||
Short-term lease liabilities | 4,574 | 4,597 | ||
Other | 17,028 | 13,198 | ||
Total | $ 163,011 | $ 181,350 |
Other Liabilities (Other Long-T
Other Liabilities (Other Long-Term Liabilities and Deferred Income Taxes) (Details) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
Payables and Accruals [Abstract] | ||
Accrued warranty | $ 17,718 | $ 19,926 |
Transition tax related to 2017 U.S. tax reform act | 11,009 | 11,009 |
Long-term lease liabilities | 14,324 | 13,664 |
Unrecognized tax benefits | 15,252 | 17,176 |
Deferred income taxes | 1,507 | 1,508 |
Other | 5,779 | 5,369 |
Total | $ 65,589 | $ 68,652 |
Product Warranties (Narrative)
Product Warranties (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Dec. 31, 2023 | |
Product Warranty Liability [Line Items] | ||
Accrued warranty reported in accrued expenses and other liabilities | $ 25,916 | $ 27,283 |
Accrued warranty | $ 17,718 | $ 19,926 |
Minimum | ||
Product Warranty Liability [Line Items] | ||
Service warranties on lasers and amplifiers | 1 year | |
Maximum | ||
Product Warranty Liability [Line Items] | ||
Service warranties on lasers and amplifiers | 5 years |
Product Warranties (Summary of
Product Warranties (Summary of Product Warranty Activity) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] | ||
Balance, beginning of period | $ 47,209 | $ 52,862 |
Provision for warranty accrual | 1,680 | 4,375 |
Warranty claims | (4,568) | (3,798) |
Foreign currency translation | (687) | 400 |
Balance, end of period | $ 43,634 | $ 53,839 |
Financing Arrangements (Narrati
Financing Arrangements (Narrative) (Details) € in Thousands, $ in Thousands | Mar. 31, 2024 USD ($) | Mar. 31, 2024 EUR (€) | Dec. 31, 2023 USD ($) |
U S Line Of Credit | |||
Debt Instrument [Line Items] | |||
Guarantees issued | $ 2,711 | $ 2,487 | |
Foreign Subsidiary Drawings On US Line Of Credit | |||
Debt Instrument [Line Items] | |||
Line of credit | 0 | $ 0 | |
Letter of Credit | U S Line Of Credit | |||
Debt Instrument [Line Items] | |||
Borrowing capacity | 75,000 | ||
Total unused credit lines and overdraft facilities | 72,289 | ||
Letter of Credit | Euro Line Of Credit | |||
Debt Instrument [Line Items] | |||
Borrowing capacity | $ 7,014 | € 6,500 |
Commitments and Contingencies (
Commitments and Contingencies (Details) | Mar. 31, 2024 USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
Legal proceedings | $ 0 |
Income Taxes (Narrative) (Detai
Income Taxes (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | ||
Effective tax rate | 28.30% | 27.80% |
Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount | $ 1,997 | $ 1,972 |
Income Taxes (Schedule of Unrec
Income Taxes (Schedule of Unrecognized Tax Benefits) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | ||
Balance, beginning of period | $ 17,176 | $ 15,841 |
Change in prior period positions | (2,000) | |
Change in prior period positions | 42 | |
Additions for tax positions in current period | 76 | 0 |
Foreign currency translation | 0 | |
Foreign currency translation | (78) | |
Balance, end of period | $ 15,252 | $ 15,805 |
Net Income Attributable to IP_3
Net Income Attributable to IPG Photonics Corporation Per Common Share (Computation of Diluted Net Income) (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Earnings Per Share [Abstract] | ||
Net income attributable to IPG Photonics Corporation common stockholders | $ 24,099 | $ 60,135 |
Basic weighted average common shares | 45,960,476 | 47,542,071 |
Dilutive effect of common stock equivalents (in shares) | 214,042 | 234,050 |
Diluted weighted average common shares | 46,174,518 | 47,776,121 |
Basic net income attributable to IPG Photonics Corporation per common share (in dollars per share) | $ 0.52 | $ 1.26 |
Diluted net income attributable to IPG Photonics Corporation per common share (in dollars per share) | $ 0.52 | $ 1.26 |
Net Income Attributable to IP_4
Net Income Attributable to IPG Photonics Corporation Per Common Share (Anti Dilutive Shares Excluded From EPS) (Details) - shares | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Excluded from computation of diluted weighted average common shares | 841,288 | 920,997 |
Non-qualified stock options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Excluded from computation of diluted weighted average common shares | 592,393 | 543,408 |
Restricted stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Excluded from computation of diluted weighted average common shares | 239,769 | 346,729 |
Performance stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Excluded from computation of diluted weighted average common shares | 0 | 30,860 |
Employee stock purchase plan | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Excluded from computation of diluted weighted average common shares | 9,126 | 0 |
Net Income Attributable to IP_5
Net Income Attributable to IPG Photonics Corporation Per Common Share (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Feb. 13, 2024 | |
Equity, Class of Treasury Stock [Line Items] | ||
Decrease in weighted average number of shares outstanding treasury stock | 436,884 | |
February 2024 Purchase Plan | ||
Equity, Class of Treasury Stock [Line Items] | ||
Share repurchase authorized amount | $ 300 | |
May 2023 Purchase Plan | ||
Equity, Class of Treasury Stock [Line Items] | ||
Stock repurchased during period (in shares) | 957,925 | |
Stock repurchase average price (in dollars per share) | $ 92.73 |